. Author manuscript; available in PMC: 2017 Nov 1.

Published in final edited form as: Curr Opin Nephrol Hypertens. 2016 Nov;25(6):536–544. doi: 10.1097/MNH.0000000000000280

Table 1.

Management of acute coronary syndromes in dialysis patients. STEMI, ST-segment elevation myocardial infarction; NSTE-ACS, non ST-segment elevation acute coronary syndrome

For all patients	Oxygen
	Aspirin
	β-blockers
	Statins
	Renin-angiotensin system blockade
If STEMI	Reperfusion therapy: percutaneous coronary intervention (or thrombolytics)
If STEMI	ADP receptor blocker: clopidogrel, prasugrel, or ticagrelor
If NSTE-ACS	Nitrates for symptom control
	P2Y₁₂ inhibition, preferably with ticagrelor
	Anticoagulation: fondaparinux, bivalirudin, heparin, or enoxaparin
	Consider coronary angiography +/− revascularization based on individual risk profile